Trade Mark Journal No.2025/045 7 November 2025
UK00004285170 28 October 2025 (5,42)
Mark 1

Mark 2

- Class 5
- Pharmaceutical, biological and biotechnological products, preparations, substances and diagnostic reagents for the prevention, detection, diagnosis and/or treatment of cancer, auto-immune diseases and other diseases.
- Class 42
- Scientific and biomedical research, development, testing and commercialization of pharmaceutical, biological and biotechnological products, preparations, substances and diagnostic reagents for the prevention, detection, diagnosis and/or treatment of cancer, auto-immune diseases and other diseases; consultancy, advisory and/or information services relating to or connected with the aforesaid services.
Alethio Therapeutics Limited
Representative: Penningtons Manches Cooper LLP